2.21
Stato iperglicemico iperosmolare
Lo stato iperglicemico iperosmolare, o HHS, è una complicanza grave e potenzialmente fatale del diabete mellito di tipo 2. È caratterizzato da tre car…
Lo Stato Ipoglicemico Iperosmolare, o HHS, è una complicanza potenzialmente letale del diabete di tipo 2 caratterizzata da gravi iperglicemia, profonda disidratazione e elevata osmolalità sierica senza chetoacidosi significativa.
Spesso deriva da una grave resistenza all'insulina e una relativa carenza di insulina, specialmente negli anziani o in chi ha un apporto di liquidi limitato a causa di malattie, o da farmaci come diuretici e corticosteroidi.
Questi fattori, combinati con la diuresi osmotica causata da una glicemia estremamente alta, portano a una massiccia perdita di liquidi e a un aumento dell'osmolalità sierica.
A differenza della chetoacidosi diabetica, i pazienti con HHS producono abbastanza insulina per inibire la formazione di chetoni ma non abbastanza per controllare la glicemia nel sangue, con conseguenti chetoni minimi o assenti e nessuna acidosi significativa.
Nel HHS, la glicemia supera i 600 milligrammi per decilitro, ben al di sopra della soglia di riassorbimento renale, portando all'escrezione di glucosio nelle urine, diuresi osmotica e a un aumento dell'osmolalità sierica superiore a 320 milliosmoli per chilogrammo.
View the full transcript and gain access to JoVE Core videos
Q1: What are the three main features that define hyperosmolar hyperglycemic state?
Hyperosmolar hyperglycemic state is characterized by severe hyperglycemia, profound dehydration, and elevated serum osmolality without significant ketoacidosis. Blood glucose typically exceeds 600 milligrams per deciliter, while serum osmolality rises above 320 milliosmoles per kilogram. These three features distinguish HHS from other diabetic emergencies and define its pathophysiologic profile.
Q2: How does hyperosmolar hyperglycemic state differ from diabetic ketoacidosis?
In HHS, patients produce enough insulin to suppress ketone formation but insufficient insulin to control blood glucose, resulting in minimal or absent ketones and no significant acidosis. In contrast, diabetic ketoacidosis involves severe insulin deficiency that promotes fat breakdown and ketone production. This fundamental difference in insulin availability explains why HHS lacks the metabolic acidosis characteristic of diabetic ketoacidosis.
Q3: What causes osmotic diuresis in hyperosmolar hyperglycemic state?
When blood glucose exceeds the renal reabsorption threshold, glucose is excreted in urine, triggering osmotic diuresis. This massive fluid loss concentrates the blood and elevates serum osmolality. Combined with reduced fluid intake from illness, medications like diuretics or corticosteroids, and severe insulin resistance, osmotic diuresis leads to profound dehydration characteristic of HHS.
Q4: Why are older adults at higher risk for developing hyperosmolar hyperglycemic state?
Older adults are vulnerable to HHS due to limited fluid intake from illness, cognitive impairment, or reduced thirst sensation. Combined with age-related changes in insulin secretion and the effects of medications such as diuretics and corticosteroids, these factors create conditions favoring severe hyperglycemia and dehydration. Older individuals may also have difficulty recognizing early warning signs.
Q5: What neurologic symptoms can result from elevated serum osmolality in HHS?
As serum osmolality rises above 320 milliosmoles per kilogram, water shifts from inside cells into the bloodstream to balance the concentration gradient. Brain cells are particularly sensitive to this shift, causing confusion, lethargy, seizures, and coma. These neurologic symptoms can resemble stroke, making rapid blood glucose testing essential for proper diagnosis and differentiation.
Q6: What role does insulin resistance play in hyperosmolar hyperglycemic state development?
HHS arises from severe insulin resistance combined with relative insulin deficiency, preventing adequate glucose control despite some residual insulin production. This partial insulin activity is sufficient to inhibit ketone formation but insufficient to prevent dangerous blood glucose elevation. Severe insulin resistance is the primary driver distinguishing HHS pathophysiology in type 2 diabetes.
Q7: How does the renal reabsorption threshold contribute to fluid loss in HHS?
The kidneys can only reabsorb glucose up to a specific threshold; when blood glucose exceeds 600 milligrams per deciliter, excess glucose cannot be reabsorbed and is excreted in urine. This glucose excretion creates an osmotic gradient that draws water into the urine, causing substantial fluid loss and further concentrating blood solutes. This mechanism perpetuates the cycle of dehydration and rising serum osmolality.